NCT00515593View on ClinicalTrials.gov

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

July 31, 2008

Conditions
PostmenopauseOsteoporosis
Interventions
DRUG

Parathyroid hormone (PTH) (Preotact)

Patients with severe postmenopausal osteoporosis

Trial Locations (1)

Unknown

Nycomed Deutschland GmbH, Cities in Germany

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT00515593 - PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE) | Biotech Hunter | Biotech Hunter